Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
27,694
Total Claims
$2.5M
Drug Cost
634
Beneficiaries
$4,009
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-80%
Opioid rate vs peers
0.4% vs 2.2% avg
+184%
Cost per patient vs peers
$4,009 vs $1,411 avg
+87%
Brand preference vs peers
19.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.4%
Opioid Rate
124
Opioid Claims
$7,296
Opioid Cost
16.1%
Long-Acting Rate
Brand vs Generic
Brand: 5,492 claims · $1.8M
Generic: 22,082 claims · $694K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,184 | $331K |
| Valbenazine Tosylate | 45 | $170K |
| Deutetrabenazine | 34 | $100K |
| Fluticasone/Umeclidin/Vilanter | 153 | $83K |
| Dulaglutide | 76 | $70K |
| Rivaroxaban | 252 | $69K |
| Empagliflozin | 212 | $61K |
| Brexpiprazole | 67 | $55K |
| Dimethyl Fumarate | 11 | $55K |
| Pimavanserin Tartrate | 19 | $44K |
| Sacubitril/Valsartan | 106 | $33K |
| Rifaximin | 25 | $32K |
| Ubrogepant | 23 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 92 | $29K |
| Cariprazine Hcl | 40 | $27K |
Prescribing Profile
Patient Profile
78
Avg Age
59%
Female
2.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About